SCHEMBL15624619

SCHEMBL15624619

CCOc1nc(-c2cc(OC)ccc2N)cs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 2/20 0.44
▸ CYP1B1 Q16678 2/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ MAPT P10636 6/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10304992 0.85 CYP1A1 (0.45) CYP1A1CYP1B1MEN1KMT2AL3MBTL1
SCHEMBL15624576 0.83 RAB9A (0.40) MEN1KMT2AL3MBTL1MAPTALDH1A1
SCHEMBL15624574 0.74 CYP11B1 (0.44) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL10305109 0.72 CYP1A1 (0.50) CYP1A1CYP1B1MEN1KMT2AL3MBTL1
SCHEMBL11004268 0.69 ALDH1A1 (0.61) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL30206740 0.69 ALDH1A1 (0.61) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL30206743 0.69 ALDH1A1 (0.61) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL10305054 0.69 ATP4A (0.48) CYP19A1MAPTSMN1; SMN2ALDH1A1NPC1
SCHEMBL30641473 0.69 ALDH1A1 (0.71) CYP1A1CYP1B1MEN1KMT2AL3MBTL1
SCHEMBL5327111 0.69 ALDH1A1 (0.71) CYP1A1CYP1B1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2252595-B1 OXIM DERIVATIVES AS HSP90 INHIBITORS TAKEDA PHARMACEUTICAL (JP) 2014-03-26 — — EP disclosed
Send feedback